About
NexPlasmaGen incorporated is a Canadian privately held company dedicated to providing noninvasive plasma technologies to the health care systems to fight cancer. We first focus on reducing breast cancer recurrence rates to improve patients' survival rates at difference local stages of the disease and to reduce hospital's and patient's costs associated with recurrence. Our plasma technology is safe, efficient, versatile and portable and has been proven in preclinical trials. Safety clinical trials are in preparation for 2023.
Technologies
Microsoft Office 365
Mobile Friendly
Google Tag Manager
Google Maps
WordPress.org
YouTube
Apache
Google Font API
Google Maps (Non Paid Users)
Render
IoT
AI
Remote
Keywords
oncology & breast cancer
medical equipment manufacturing
oncology
targeted cancer therapy
preclinical cancer research
residual cancer cell elimination
controlled plasma environment
clinical trial preparation
plasma-based cancer ablation
cold plasma therapy
cancer treatment
breast cancer
healthcare technology
surgical adjunct technology
post-surgical cancer treatment
patented plasma technology
plasma jet device
b2b
plasma device patents
preclinical trials
healthcare
reactive species delivery
non-thermal plasma
medical device innovation
in vitro and in vivo studies
services
biotechnology
recurrence reduction
medical equipment and supplies manufacturing
cancer recurrence prevention
Company Information
-
Employees 9
-
Founded 2008
Location
3801 Avenue Wilson, Montreal, Quebec, Canada, H4A 2T7
